Mary Reyland PhD

Publications and Presentations

• B Allen-Petersen*, AR Miller*, SM Anderson, MC Neville, KI Nakayama and ME Reyland 2010. Loss of Protein Kinase Cdelta alters mammary gland development and apoptosis, *equal contributions. Cell Death and Disease 1:1-9
• ME Reyland and AP Bradford 2010. PKC isoforms and the control of apoptosis. MG Kazanietz (ed.), Protein Kinase C in Cancer Signaling and Therapy, DOI 10.1007/978-1-60761-543-9_9
• A Vissink, JB Mitchell, BJ Baum, KH Limesand, S Beier-Jensen, PC Fox, LS Elting, JA Langendijk, RP Coppes, and ME Reyland 2010. Oral Complications of Emerging Cancer Therapies. Int J Rad Biology Biophysics 78:983-91
• JM Symonds, AM Ohm, CJ Carter, LE Heasley, TA Aly, WA Franklin and ME Reyland 2011. Protein kinase Cdelta is a downstream effector of oncogenic KRAS in K-Ras-dependent lung tumors. Cancer Res 71:2087-2097
• TS Adwan, AM Ohm, DNM Jones, MJ Humphries and ME Reyland 2011. Regulated Binding of Importin-alpha to PKCdelta in Response to Apoptotic Signals Facilitates  Nuclear Import.  J Biol Chem, 286:35716-35724